BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9883901)

  • 1. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling.
    Helman D; Sandowski Y; Cohen Y; Matsumoto A; Yoshimura A; Merchav S; Gertler A
    FEBS Lett; 1998 Dec; 441(2):287-91. PubMed ID: 9883901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
    Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
    Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
    Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
    Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
    Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of novel CIS family genes.
    Masuhara M; Sakamoto H; Matsumoto A; Suzuki R; Yasukawa H; Mitsui K; Wakioka T; Tanimura S; Sasaki A; Misawa H; Yokouchi M; Ohtsubo M; Yoshimura A
    Biochem Biophys Res Commun; 1997 Oct; 239(2):439-46. PubMed ID: 9344848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A
    Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
    Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells.
    Tonko-Geymayer S; Goupille O; Tonko M; Soratroi C; Yoshimura A; Streuli C; Ziemiecki A; Kofler R; Doppler W
    Mol Endocrinol; 2002 Jul; 16(7):1680-95. PubMed ID: 12089360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins.
    Ben-Yair L; Slaaby R; Herman A; Cohen Y; Biener E; Moran N; Yoshimura A; Whittaker J; De Meyts P; Herman B; Gertler A
    Protein Expr Purif; 2002 Aug; 25(3):456-64. PubMed ID: 12182826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of cytokine signaling pathways.
    Yasukawa H; Sasaki A; Yoshimura A
    Annu Rev Immunol; 2000; 18():143-64. PubMed ID: 10837055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
    Ram PA; Waxman DJ
    J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CIS family: negative regulators of JAK-STAT signaling.
    Yoshimura A
    Cytokine Growth Factor Rev; 1998; 9(3-4):197-204. PubMed ID: 9918119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
    Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
    Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CIS/JAB family: novel negative regulators of JAK signaling pathways.
    Yoshimura A
    Leukemia; 1998 Dec; 12(12):1851-7. PubMed ID: 9844915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.